Quinacrine Has Preferential Anticancer Effects on Mesothelioma Cells With Inactivating NF2 Mutations

This study suggests quinacrine may have repurposing potential for a large subset of mesothelioma patients.
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research